Morreau Jane Cecil

SEC source: 0001482981-26-000152 · form4.xml · nonDerivative · entry 1

Morreau Jane Cecil · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,709

F1 · shares: Represents deferred RSUs granted under the Issuers 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on the date the Reporting Person ceases service on the Board. Each deferred RSU represents the right to receive one share of common stock of the Issuer.

SEC source: 0001259381-26-000002 · primary_doc.xml · nonDerivative · entry 1

Morreau Jane Cecil · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,778

F1 · shares: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2032.

SEC source: 0001482981-26-000026 · form4.xml · derivative · entry 7

Morreau Jane Cecil · CIK 0001259381 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,500

Underlying: Common Stock · 5,000 shares

Expires 2031-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

SEC source: 0001482981-26-000026 · form4.xml · derivative · entry 6

Morreau Jane Cecil · CIK 0001259381 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 5,000 shares

Expires 2031-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

SEC source: 0001482981-26-000026 · form4.xml · derivative · entry 5

Morreau Jane Cecil · CIK 0001259381 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,500

Underlying: Common Stock · 5,000 shares

Expires 2031-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

SEC source: 0001482981-26-000026 · form4.xml · nonDerivative · entry 4

Morreau Jane Cecil · CIK 0001259381 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,179

F1 · kind: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001482981-26-000026 · form4.xml · nonDerivative · entry 3

Morreau Jane Cecil · CIK 0001259381 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001482981-26-000026 · form4.xml · nonDerivative · entry 2

Morreau Jane Cecil · CIK 0001259381 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001482981-26-000026 · form4.xml · nonDerivative · entry 1

Morreau Jane Cecil · CIK 0001259381 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001835207-25-000032 · primary_doc.xml · nonDerivative · entry 1

Morreau Jane Cecil · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,340

F1 · shares: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2031.

SEC source: 0001482981-25-000105 · edgardoc.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,179

F1 · shares: Represents deferred RSUs granted under the Issuers 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on the date the Reporting Person ceases service on the Board. Each deferred RSU represents the right to receive one share of common stock of the Issuer.

SEC source: 0001835207-25-000005 · primary_doc.xml · derivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,430

Underlying: Subordinate Voting Shares · 32,430 shares

Expires 2032-03-25

F1 · derivative.exercise_date: The options are fully vested.

SEC source: 0001482981-24-000194 · edgardoc.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,893

F1 · shares: Represents RSUs granted under the Company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided the Reporting Person remains in continuous service on the applicable vesting date.

SEC source: 0001790300-24-000018 · primary_doc.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,730

SEC source: 0001482981-24-000079 · edgardoc.xml · nonDerivative · entry 2

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,264

F2 · shares: Represents deferred RSUs granted under the Issuers 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on the date the Reporting Person ceases service on the Board. Each deferred RSU represents the right to receive one share of common stock of the Issuer.

SEC source: 0000950170-24-030344 · ownership.xml · derivative · entry 2

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,580

Underlying: Subordinate Voting Shares · 13,580 shares

Expires 2031-03-08

F2 · derivative.exercise_date: The options are fully vested.

SEC source: 0000950170-24-030344 · ownership.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,495

F1 · shares: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. The RSUs will vest on April 7, 2024.

SEC source: 0001209191-23-043605 · doc4.xml · derivative · entry 2

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,597

Underlying: Subordinate Voting Shares · 25,597 shares

Expires 2030-07-24

F2 · derivative.exercise_date: All of the options became exercisable upon grant on July 25, 2023.

SEC source: 0001209191-23-043605 · doc4.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,995

F1 · kind: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. All of the RSUs will vest on August 24, 2023.

SEC source: 0001209191-24-001664 · doc4a.xml · derivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,597

Underlying: Subordinate Voting Shares · 25,597 shares

Expires 2030-07-24

F1 · derivative.exercise_price: The original Form 4 filed on July 27, 2023, is amended by this Form 4 amendment to correct column 2 (Conversion or Exercise Price of Derivative Security), which was incorrectly reported in the original filing due to a clerical error.

F2 · derivative.exercise_date: All of the options became exercisable upon grant on July 25, 2023.

SEC source: 0001482981-23-000062 · edgardoc.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,017

F1 · shares: Represents RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date.

SEC source: 0001482981-24-000079 · edgardoc.xml · derivative · entry 3

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,757 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each deferred RSU represents the right to receive one share of common stock of the Issuer. On June 1, 2022, the Reporting Person was granted a deferred RSU that vested in full on June 1, 2023. The deferred RSU will settle on the date the Reporting Person ceases service on the Board.

F1 · derivative.exercise_date: Each deferred RSU represents the right to receive one share of common stock of the Issuer. On June 1, 2022, the Reporting Person was granted a deferred RSU that vested in full on June 1, 2023. The deferred RSU will settle on the date the Reporting Person ceases service on the Board.

F1 · derivative.expiration_date: Each deferred RSU represents the right to receive one share of common stock of the Issuer. On June 1, 2022, the Reporting Person was granted a deferred RSU that vested in full on June 1, 2023. The deferred RSU will settle on the date the Reporting Person ceases service on the Board.

SEC source: 0001482981-24-000079 · edgardoc.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,090

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each deferred RSU represents the right to receive one share of common stock of the Issuer. On June 1, 2022, the Reporting Person was granted a deferred RSU that vested in full on June 1, 2023. The deferred RSU will settle on the date the Reporting Person ceases service on the Board.

SEC source: 0000899243-22-020825 · doc4.xml · derivative · entry 3

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,757

Underlying: Common Stock · 5,757 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer. The deferred stock units granted under the company's 2021 Incentive Award Plan vest in full the earlier of (i) the day immediately preceding the first Annual Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date, and will settle on the date the Reporting Person ceases service on the Board.

F3 · derivative.exercise_date: Each deferred stock unit represents the right to receive one share of common stock of the Issuer. The deferred stock units granted under the company's 2021 Incentive Award Plan vest in full the earlier of (i) the day immediately preceding the first Annual Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date, and will settle on the date the Reporting Person ceases service on the Board.

F3 · derivative.expiration_date: Each deferred stock unit represents the right to receive one share of common stock of the Issuer. The deferred stock units granted under the company's 2021 Incentive Award Plan vest in full the earlier of (i) the day immediately preceding the first Annual Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date, and will settle on the date the Reporting Person ceases service on the Board.

SEC source: 0000899243-22-020825 · doc4.xml · derivative · entry 2

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: RSUs were granted on October 21, 2021 with a vesting date of the earlier of (i) the day immediately preceding the first Annual Meeting after the grant date or (ii) on October 21, 2022 provided that the Reporting Person remains in continuous service on the applicable vesting date.

F2 · derivative.expiration_date: RSUs were granted on October 21, 2021 with a vesting date of the earlier of (i) the day immediately preceding the first Annual Meeting after the grant date or (ii) on October 21, 2022 provided that the Reporting Person remains in continuous service on the applicable vesting date.

SEC source: 0000899243-22-020825 · doc4.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") convert to common stock on a one-for-one basis.

SEC source: 0001209191-22-013805 · doc4.xml · derivative · entry 2

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,386

Underlying: Subordinate Voting Shares · 10,386 shares

Expires 2029-02-24

F2 · derivative.exercise_date: The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2022, one-third vesting on December 1, 2023, and one-third vesting on December 1, 2024.

SEC source: 0001209191-22-013805 · doc4.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,492

F1 · kind: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2023, and the remaining 50% of the RSUs will vest on December 1, 2024.

SEC source: 0001754195-21-000068 · edgar.xml · derivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,793

Underlying: Subordinate Voting Shares · 8,793 shares

Expires 2026-10-26

F1 · derivative.exercise_date: The option becomes exercisable in two annual installments, with 50% vesting on December 31, 2021 and 50% vesting on December 31, 2022.

SEC source: 0000899243-21-041440 · doc4.xml · derivative · entry 1

MORREAU JANE C · CIK 0001259381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,333

Underlying: Common Stock · 2,333 shares

Expires not disclosed

F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs will vest in full the earlier of (i) the day immediately preceding the first Annual Meeting after the grant date or (ii) on October 21, 2022 provided that the Reporting Person remains in continuous service on the applicable vesting date. Unless otherwise provided, on the applicable vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs will vest in full the earlier of (i) the day immediately preceding the first Annual Meeting after the grant date or (ii) on October 21, 2022 provided that the Reporting Person remains in continuous service on the applicable vesting date. Unless otherwise provided, on the applicable vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs will vest in full the earlier of (i) the day immediately preceding the first Annual Meeting after the grant date or (ii) on October 21, 2022 provided that the Reporting Person remains in continuous service on the applicable vesting date. Unless otherwise provided, on the applicable vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

SEC source: 0000014693-21-000073 · wf-form4_162276000577105.xml · nonDerivative · entry 2

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,654

F2 · shares: To satisfy withholding obligations associated with the July 26, 2018 award of performance-based restricted stock units that were issued as shares on June 1, 2021, the reporting person surrendered 2,402 shares of Class A common stock.

F3 · price: The closing price of BF-A on April 30, 2021 was used to calculate the withholding obligation.

SEC source: 0000014693-21-000073 · wf-form4_162276000577105.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,056

F1 · shares: These shares were issued on June 1, 2021, in connection with a July 26, 2018 award of performance-based restricted stock units. The award was subject to a three-year performance period, which ended April 30, 2021.

SEC source: 0000014693-21-000002 · wf-form4_160988230967916.xml · derivative · entry 4

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common · 28,267 shares

Expires 2022-04-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000014693-21-000002 · wf-form4_160988230967916.xml · nonDerivative · entry 3

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,040

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.38 to $79.82, inclusive. The reporting person undertakes to provide to Brown-Forman Corporation, any security holder of Brown-Forman Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000014693-21-000002 · wf-form4_160988230967916.xml · nonDerivative · entry 2

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,564

F2 · price: The closing price of BF-B on December 31, 2020 was used to calculate the withholding obligation.

SEC source: 0000014693-21-000002 · wf-form4_160988230967916.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Total updated to reflect the transfer of ESPP shares to direct holdings.

SEC source: 0000014693-20-000104 · wf-form4_159648845902939.xml · derivative · entry 1

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,933

Underlying: Class B Common · 23,933 shares

Expires 2030-04-30

F1 · security: No money was paid to or received by the reporting person for these SSARs.

SEC source: 0000014693-20-000036 · wf-form4_159121737697650.xml · nonDerivative · entry 4

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,591.8464

F5 · shares: To satisfy withholding obligations associated with the July 27, 2017 award of performance-based restricted stock units that were issued as shares on June 1, 2020, the reporting person surrendered 926 shares of Class B common stock.

F6 · price: The closing price of BF-B on April 30, 2020 was used to calculate the withholding obligation.

SEC source: 0000014693-20-000036 · wf-form4_159121737697650.xml · nonDerivative · entry 3

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,517.8464

F1 · shares: These shares were issued on June 1, 2020, in connection with a July 27, 2017 award of performance-based restricted stock units. The award was subject to a three-year performance period, which ended April 30, 2020.

F2 · balance_after: Total updated to reflect dividend reinvestment.

SEC source: 0000014693-20-000036 · wf-form4_159121737697650.xml · nonDerivative · entry 2

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,896.2324

F3 · shares: To satisfy withholding obligations associated with the July 27, 2017 award of performance-based restricted stock units that were issued as shares on June 1, 2020, the reporting person surrendered 3,700 shares of Class A common stock.

F4 · price: The closing price of BF-A on April 30, 2020 was used to calculate the withholding obligation.

SEC source: 0000014693-20-000036 · wf-form4_159121737697650.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,596.2324

F1 · shares: These shares were issued on June 1, 2020, in connection with a July 27, 2017 award of performance-based restricted stock units. The award was subject to a three-year performance period, which ended April 30, 2020.

F2 · balance_after: Total updated to reflect dividend reinvestment.

SEC source: 0000014693-20-000002 · wf-form4_157834544668742.xml · derivative · entry 5

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common · 36,588 shares

Expires 2021-04-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000014693-20-000002 · wf-form4_157834544668742.xml · nonDerivative · entry 3

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,489.16

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.67, inclusive. The reporting person undertakes to provide to Brown-Forman Corporation, any security holder of Brown-Forman Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000014693-20-000002 · wf-form4_157834544668742.xml · nonDerivative · entry 2

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,894.16

F2 · price: The closing price of BF-B on December 31, 2019 was used to calculate the withholding obligation.

SEC source: 0000014693-20-000002 · wf-form4_157834544668742.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,077.16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Total has been updated to reflect dividend reinvestment.

SEC source: 0000014693-19-000110 · wf-form4_156443490584756.xml · derivative · entry 1

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,416

Underlying: Class B Common · 31,416 shares

Expires 2029-04-30

F1 · security: No money was paid to or received by the reporting person for these SSARs.

SEC source: 0000014693-19-000062 · wf-form4_155977077616562.xml · nonDerivative · entry 4

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,449.037

F4 · shares: To satisfy withholding obligations associated with the July 28, 2016 award of performance-based restricted stock units that were issued as shares on June 3, 2019, the reporting person surrendered 1,032 shares of Class B common stock.

F5 · price: The closing price of BF-B on April 30, 2019 was used to calculate the withholding obligation.

SEC source: 0000014693-19-000062 · wf-form4_155977077616562.xml · nonDerivative · entry 3

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,481.037

F1 · shares: These shares were issued on June 3, 2019, in connection with a July 28, 2016 award of performance-based restricted stock units. The award was subject to a three-year performance period, which ended April 30, 2019.

SEC source: 0000014693-19-000062 · wf-form4_155977077616562.xml · nonDerivative · entry 2

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,304.0398

F2 · shares: To satisfy withholding obligations associated with the July 28, 2016 award of performance-based restricted stock units that were issued as shares on June 3, 2019, the reporting person surrendered 4,128 shares of Class A common stock.

F3 · price: The closing price of BF-A on April 30, 2019 was used to calculate the withholding obligation.

SEC source: 0000014693-19-000062 · wf-form4_155977077616562.xml · nonDerivative · entry 1

MORREAU JANE C · CIK 0001259381 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,432.0398

F1 · shares: These shares were issued on June 3, 2019, in connection with a July 28, 2016 award of performance-based restricted stock units. The award was subject to a three-year performance period, which ended April 30, 2019.